Retrospective evaluation of pregnancy outcomes in women with familial Mediterranean fever

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 27, Issue 7, 2014, Pages 733-736

  Yasar, Ozlem ^a   Iskender, Cantekin ^a   Kaymak, Oktay ^a   Taflan Yaman, Selen ^a   Uygur, Dilek ^a   Danisman, Nuri ^a  

^a Dr Zekai Tahir Burak Training and Research Hospital   (Turkey)

Author keywords

Familial mediterranean fever; Pregnancy complications; Prenatal care

Indexed keywords

COLCHICINE; TUBULIN MODULATOR;

ADULT; ARTICLE; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG USE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMAN; LOW BIRTH WEIGHT; MATERNAL AGE; MEDICAL HISTORY; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; PROTEINURIA; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION; STILLBIRTH; TURKEY (REPUBLIC); ADOLESCENT; EPIDEMIOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS; TURKEY; YOUNG ADULT;

ADOLESCENT; ADULT; COLCHICINE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; TUBULIN MODULATORS; TURKEY; YOUNG ADULT;

EID: 84897557138     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.837446     Document Type: Article

References (28)

1. Eliakim M, Levy M, Ehrenfeld M. Recurrent polyserositis (familial Mediterranean fever, periodic disease). New York: Elsevier/North-Holland; 1981:5-14.
2. Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet 1998; 351:659-64.
3. Tunca M, Akar S, Onen F, et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine 2005;84:1-11.
4. Cobankara V, Fidan G, Turk T, et al. The prevalence of familial Mediterranean fever in the Turkish province of Denizli: a field study with a zero patient design. Clin Exp Rheumatol 2004;22: S27-30.
5. Samuels J, Aksentijevich I, Torosyan Y, et al. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the national institutes of health. Medicine 1998;77:268-97.
6. Mor A, Gal R, Livneh A. Abdominal and digestive system associations of familial Mediterranean fever. Am J Gastroenterol 2003;98:2594-604.
7. Ben-Chetrit E, Levy M. Reproductive system in familial Mediterranean fever: an overview. Ann Rheum Dis 2003;62:916-9.
8. Ben-Chetrit E, Levy M. Colchicine update 1998 Semin Arthritis Rheum 1998;28:48-59.
9. Zemer D, Pras M, Sohar E, et al. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 1986;314:1001-3.
10. Matzner Y. Biologic and clinical advances in familial Mediterranean fever. Crit Rev Oncol Hematol 1995;18:197-205.
11. Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40: 1879-85.
12. Ofir D, Levy A, Wiznitzer A, et al. Familial Mediterranean fever during pregnancy: an independent risk factor for preterm delivery. Eur J Obstet Gynecol Reprod Biol 2008;141:115-8.
13. Tunca M, Tankurt E. The efficacy of interferon alpha on colchicine resistant FMF attacks. Br J Rheumatol 1997;36:1005-8.
14. Diav-Citrin O, Shechtman S, Schwartz V, et al. Pregnancy outcome after in utero exposure to colchicine. Am J Obstet Gynecol 2010; 203:144.e1-6.
15. Ben-Chetrit E, Ben-Chetrit A, Berkun Y, Ben-Chetrit E. Pregnancy outcomes in women with familial Mediterranean fever receiving colchicine: is amniocentesis justified? Arthritis Care Res 2010;62: 143-8.
16. Gomez R, Romero R, Edwin SS, David C. Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intraamniotic infection. Infect Dis Clin North Am 1997;11:135-76.
17. Fortunato SJ, Menon R, Lombardi SJ. Support for an infectioninduced apoptotic pathway in human fetal membranes. Am J Obstet Gynecol 2001;184:1392-7.
18. Romero R, Friel LA, Velez Edwards DR, et al. A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM). Am J Obstet Gynecol 2010;203:361.
19. Ferrand PE, Parry S, Sammel M, et al. A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod 2002;8:494-501.
20. Fujimoto T, Parry S, Urbanek M, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J Biol Chem 2002;277:6296-302.
21. Romero R, Gotsch F, Pineles B, Kusanovic JP. Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev 2007;65:S194-02.
22. Hassan SS, Romero R, Haddad R, et al. The transcriptome of the uterine cervix before and after spontaneous term parturition. Am J Obstet Gynecol 2006;195:778-86.
23. Haddad R, Gould BR, Romero R, et al. Uterine transcriptomes of bacteria-induced and ovariectomy-induced preterm labor in mice are characterized by differential expression of arachidonate metabolism genes. Am J Obstet Gynecol 2006;195:822-8.
24. Rabinovitch O, Zemer D, Kukia E, et al. Colchicine treatment in conception and pregnancy: 231 pregnancies with familial Mediterranean fever. Am J Reprod Immunol 1992;28:245-6.
25. Ferreira NR, Buoniconti A. Trisomy after colchicine therapy. Lancet 1968;2:1304.
26. Mijatovic V, Hompes PG, Wouters MG. Familial Mediterranean fever and its implications for fertility and pregnancy. Eur J Obstet Gynecol Reprod Biol 2003;108:171-6.
27. Cabili S, Livneh A, Zemer D, et al. The effect of pregnancy on renal function in amyloidosis of familial Mediterranean fever. Am J Reprod Immunol 1992;28:243-4.
28. Livneh A, Cabili S, Zemer D, et al. Effect of pregnancy on renal function in amyloidosis of familial Mediterranean fever. J Rheumatol 1993;20:1519-23.